Fidelity International’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-573,600
| Closed | -$3.18M | – | 926 |
|
|
2024
Q3 | $3.18M | Hold |
573,600
| – | – | ﹤0.01% | 664 |
|
|
2024
Q2 | $3.2M | Hold |
573,600
| – | – | ﹤0.01% | 651 |
|
|
2024
Q1 | $3.85M | Hold |
573,600
| – | – | ﹤0.01% | 621 |
|
|
2023
Q4 | $5.23M | Hold |
573,600
| – | – | 0.01% | 568 |
|
|
2023
Q3 | $3.17M | Hold |
573,600
| – | – | ﹤0.01% | 597 |
|
|
2023
Q2 | $4.9M | Sell |
573,600
-1,953
| -0.3% | -$16.7K | 0.01% | 561 |
|
|
2023
Q1 | $5.29M | Sell |
575,553
-7,809
| -1% | -$71.8K | 0.01% | 553 |
|
|
2022
Q4 | $5.96M | Hold |
583,362
| – | – | 0.01% | 553 |
|
|
2022
Q3 | $8.59M | Hold |
583,362
| – | – | 0.01% | 512 |
|
|
2022
Q2 | $6.26M | Hold |
583,362
| – | – | 0.01% | 556 |
|
|
2022
Q1 | $6.29M | Sell |
583,362
-2,083,238
| -78% | -$22.5M | 0.01% | 580 |
|
|
2021
Q4 | $43.5M | Hold |
2,666,600
| – | – | 0.04% | 327 |
|
|
2021
Q3 | $57.1M | Buy |
+2,666,600
| New | +$57.1M | 0.06% | 280 |
|